Core Viewpoint - Jin Hai Medical Technology (02225) experienced a significant stock price increase, rising over 15% during trading and currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] Group 1: Company Developments - Jin Hai Medical announced a collaboration with Medtronic China to unveil a new navigational spinal endoscopy innovation during the 8th China International Import Expo, scheduled from November 5 to 10 in Shanghai [1] - The new technology is expected to enhance precision and intelligence in spinal surgeries, reducing the learning curve for clinicians in spinal endoscopy techniques and promoting more efficient and widespread clinical applications in the future [1] Group 2: Industry Context - Medtronic's primary business includes the development, manufacturing, distribution, and sales of medical therapies and services in cardiovascular disease, neuroscience, surgical technologies, and diabetes [1] - Medtronic has established production bases in Shanghai, Changzhou, and Chengdu, and has participated in the China International Import Expo for seven consecutive years since its inception in 2018, leveraging the event's influence to showcase and accelerate the application of its latest innovative medical technologies and products [1]

Core Viewpoint - Jinhai Medical Technology (02225) experienced a significant stock increase of over 6%, closing at 1.2 HKD with a trading volume of 29.22 million HKD, driven by the announcement of a new innovative technology in spinal surgery during the China International Import Expo [1] Company Summary - Jinhai Medical is set to jointly launch a new navigation-based endoscopic technology for spinal surgery in collaboration with Medtronic China during the eighth China International Import Expo [1] - This innovative technology aims to enhance precision and intelligence in spinal surgeries, potentially shortening the learning curve for clinicians in endoscopic techniques [1] - The expected outcome is a more efficient and widespread clinical application of spinal surgery techniques, marking a significant advancement in the field [1] Industry Summary - The announcement aligns with ongoing trends in the medical technology industry towards increased precision and efficiency in surgical procedures [1] - The collaboration with a major player like Medtronic China highlights the importance of partnerships in driving innovation within the healthcare sector [1]

Core Viewpoint - The company is actively preparing to participate in the 8th China International Import Expo in November 2025, showcasing its latest innovative technology in spinal surgery [1] Group 1: Company Developments - The company's indirect wholly-owned subsidiary, Shanghai Jinhai Medical Technology Co., Ltd., is involved in the preparations for the expo [1] - During the expo, the company will collaborate with Medtronic China Orthopedic and Neurosurgery Group to launch a new navigation-based spinal endoscopy technology [1] Group 2: Industry Impact - The new technology is expected to enhance precision and intelligence in spinal surgery, potentially revolutionizing the field [1] - It aims to shorten the learning curve for clinicians in spinal endoscopy techniques, promoting more efficient and widespread clinical applications in the future [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Jinhai Medical Technology Limited 今海醫療科技股份有限公司 （股份代號：2225） （於開曼群島註冊成立的成員有限責任公司） 自願公告－業務發展最新情況 本公告乃由今海醫療科技股份有限公司（「本公司」，連同其附屬公司統稱「本集團」） 自願作出，旨在向其股東及潛在投資者提供有關本集團的業務近期發展最新情況。 本公司董事（「董事」）會（「董事會」）欣然宣佈，本公司之間接全資附屬公司上海 今海醫療科技有限公司（「今海醫療」）正在積極籌辦參加於二零二五年十一月五 日至十日在中國（「中國」）上海舉辦的第八屆中國國際進口博覽會（「進博會」）。 於第八屆進博會期間，今海醫療將與美敦力中國骨科與神外業務集團（「美敦力中 國」）聯合發佈最新研發的導航下脊柱內鏡創新技術，該技術預計可應用於脊柱外 科手術，預期將為脊柱手術的精準化與智能化發展開闢全新路徑，縮短臨床醫生 在脊柱內鏡技術上的學習 ...